Goodbye, Dolly: Rejecting Cloned Food
By Dr. Allan Kornberg,
Business Week
| 02. 21. 2007
Ten years after scientists produced the first clone of a mammal, a sheep named Dolly, the U.S. Food and Drug Administration has issued a draft assessment that moves our nation closer to the widespread sale of meat and dairy products from animal clones.
During the next two months, Americans have the opportunity to comment on the FDA's draft and influence whether or not food from animal clones ends up in our fast food and on our supermarket shelves. Debate is under way on the possible long-term risk to human health, consumer choice, and religious and ethical concerns. The one group that stands to lose the most if the FDA's assessment is accepted is the farm animals that will suffer and die to produce food and dairy products that most Americans don't want to eat. Since animals cannot speak, those of us who care about animal welfare must speak out for them.
"Unconscionable"
Over the past decade, news of Dolly's birth and subsequent announcements that scientists succeeded in producing clones of cows, pigs, goats, and other animals—even cats and dogs—have been...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...